Please assess the completion status of the following clinical trial:

Trial Title: Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Able and willing to give informed consent~* Age \> 18 years~* HIV infection as confirmed by HIV-antibody test as per Kenyan guidelines~* CD4+ T-cell count ≤100 cells/µl~* Serum CrAg titer≥1:2~* Able to travel to district hubs (Sindo District Hospital, Lumumba Health Centre) for regular study visits~Exclusion Criteria:~* clinical meningitis:~* clinical sepsis:~* hemiparesis, aphasia, visual field deficit or other finding on neurological examination localizable to the central nervous system~* a history of culture proven or suspected (cryptococcal antigen present) cryptococcal meningitis~* a history of stroke or other infection of the central nervous system~* a seizure within the last 2 months~* currently taking or ever taken antiretroviral therapy~* currently taking anti-tuberculous therapy~* currently or recently (\<2 months) prescribed fluconazole, itraconazole, clotrimazole troches, amphotericin or other oral anti-fungal medications~* pregnant or breast-feeding~* alanine aminotransferase concentration more than 3 times the upper limit of normal~* neutrophil count \<1000x103 cells/mL~* hemoglobin \<8g/dL~* platelet count \<100,000x 103 platelets/mL~* creatinine clearance ≤50 ml/min~* individuals with active heavy alcohol use or active recreational drug use

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 5FC plus fluconazole (Type: EXPERIMENTAL): Combination therapy with oral fluconazole and flucytosine
- fluconazole alone (Type: ACTIVE_COMPARATOR): Fluconazole monotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).